Reduction in the incidence of myocardial infarction with sodium–glucose linked cotransporter-2 inhibitors: evident and plausible

被引：0
|
作者：
Richard E. Gilbert
Kim A. Connelly
机构：
[1] St. Michael’s Hospital,Division of Endocrinology
[2] St. Michael’s Hospital,Division of Cardiology
来源：
Cardiovascular Diabetology | / 18卷
关键词：
Sodium–glucose linked cotransporter-2; Myocardial infarction; Cardiovascular outcome trials; Stroke;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [41] Sodium-glucose cotransporter-2 inhibitors in cardiovascular disease: a gaseous solution
    Durante, William
    MEDICAL GAS RESEARCH, 2025, 15 (02): : 206 - 207
  • [42] Impact of sodium-glucose cotransporter-2 inhibitors in patients with recent versus previous myocardial infarction: a systematic review and meta-analysis
    Scardini, Pedro Gabriel
    Katsuyama, Eric Shih
    Prata, Alonzo Armani
    Fernandes, Julia Marques
    Fukunaga, Christian Ken
    Neto, Wilson Falco
    Coan, Ana Carolina Covre
    de Andrade, Naieli Machado
    Silva, Abraao Santana
    Pinheiro, Rafael Petri
    Pereira, Luciana Gioli
    Furtado, Remo H. M.
    CARDIOVASCULAR DIABETOLOGY, 2025, 24 (01)
  • [43] Sodium-Glucose Cotransporter-2 Inhibitors After Acute Myocardial Infarction: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
    Lin, Norman H. Y.
    Ho, Jamie S. Y.
    Leow, Aloysius S. T.
    Teo, Yao Hao
    Yeo, Brian S. Y.
    Zhang, Audrey A. Y.
    Goh, Fang Qin
    Yeo, Tiong-Cheng
    Wong, Raymond C. C.
    Chai, Ping
    Chan, Mark Y. Y.
    Sia, Ching-Hui
    AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS, 2025, 25 (01) : 71 - 81
  • [44] Mortality Outcomes With Different Sodium-glucose Cotransporter-2 Inhibitors: Are They Dissimilar?
    Singh, Awadhesh Kumar
    ENDOCRINE PRACTICE, 2022, 28 (10) : 1107 - 1108
  • [45] Different Sodium-Glucose Cotransporter-2 Inhibitors: Can They Prevent Death
    Mukhopadhyay, Pradip
    Sanyal, Debmalya
    Chatterjee, Purushottam
    Pandit, Kaushik
    Ghosh, Sujoy
    ENDOCRINE PRACTICE, 2022, 28 (08) : 795 - 801
  • [46] Role of sodium glucose cotransporter-2 inhibitors in type I diabetes mellitus
    Ahmadieh, Hala
    Ghazal, Nisrine
    Azar, Sami T.
    DIABETES METABOLIC SYNDROME AND OBESITY-TARGETS AND THERAPY, 2017, 10 : 161 - 167
  • [47] Effect of sodium-glucose cotransporter-2 inhibitors on renal handling of electrolytes
    Meena, Priti
    Bhargava, Vinant
    Bhalla, Anil
    Rana, Devinder
    Mantri, Alok
    POSTGRADUATE MEDICAL JOURNAL, 2021, 97 (1154) : 819 - 824
  • [48] Sodium-glucose cotransporter-2 inhibitors in diabetes and inflammatory skin diseases
    Shen, Chin-Hsuan
    Yang, Yi-Sun
    Lee, Irene Tai-Lin
    Chiang, Meng-Han
    Chen, Steven T.
    Ma, Kevin Sheng-Kai
    BRITISH JOURNAL OF DERMATOLOGY, 2024, 191 (03) : 467 - 468
  • [49] Sodium Glucose Cotransporter-2 Inhibitors: An Overview from Evolution to Clinical Implications
    Ravi, Ramya
    Balasubramaniam, V
    Dhingra, S.
    Murti, K.
    Ponnusankar, S.
    INDIAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2024, 86 (02) : 420 - 432
  • [50] Experience with sodium glucose cotransporter-2 inhibitors in adult patients with Fontan circulation
    Skorek, Pawel
    Fraczek-Jucha, Magdalena M.
    Sarnecka, Agnieszka
    Skubera, Maciej
    Libiszewska, Natasza
    Tomkiewicz-Pajak, Lidia
    ADVANCES IN CLINICAL AND EXPERIMENTAL MEDICINE, 2025,
12345